(S)-crizotinib
CAS No. 1374356-45-2
(S)-crizotinib( (S)-Crizotinib | S-Crizotinib )
Catalog No. M17983 CAS No. 1374356-45-2
(S)-crizotinib(IC50 of 72 nM), an effective MTH1 (NUDT1) inhibitor, is the (S)-enantiomer of crizotinib.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 35 | In Stock |
|
| 5MG | 58 | In Stock |
|
| 10MG | 87 | In Stock |
|
| 25MG | 146 | In Stock |
|
| 50MG | 215 | In Stock |
|
| 100MG | 335 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product Name(S)-crizotinib
-
NoteResearch use only, not for human use.
-
Brief Description(S)-crizotinib(IC50 of 72 nM), an effective MTH1 (NUDT1) inhibitor, is the (S)-enantiomer of crizotinib.
-
Description(S)-Crizotinib is an MTH1 inhibitor. By inhibiting MTH1, (S)-Crizotinib disrupts nucleotide pool homeostasis, induces an increase in DNA single-strand breaks, activates DNA repair in human colon carcinoma cells, and effectively suppresses tumor growth in animal models.
-
In VitroCell Viability Assay Cell Line:NSCLC cells, NCI-H460, H1975 and A549 cells Concentration:0.625, 1.25, 2.5, 5, 10, 20, 40, 60, 80 μM Incubation Time:24 hours Result:Decreased the viability of NCI-H460, H1975 and A549 cells with IC50 values of 14.29, 16.54 and 11.25 μM, respectively.Apoptosis Analysis Cell Line:NSCLC cells, NCI-H460, H1975 and A549 cells Concentration:10, 20 or 30 μM Incubation Time:24 hours Result:Induced cells apoptosis.Western Blot Analysis Cell Line:NSCLC cells, NCI-H460, H1975 and A549 cells Concentration:10, 20 or 30 μM Incubation Time:24 hours Result:Decreased Bcl-2: Bax ratio.
-
In VivoAnimal Model:Five-week-old, athymic BALB/c nu/nu female mice (17-19 g) with NCI-H460 cells Dosage:7.5 or 15 mg/kg Administration:Intraperitoneal injections; once daily for 10 days Result:Resulted in significant reductions in both tumor volume and tumor weight.
-
Synonyms(S)-Crizotinib | S-Crizotinib
-
PathwayGPCR/G Protein
-
TargetCalcium Channel
-
RecptorMTH1
-
Research AreaCancer
-
Indication——
Chemical Information
-
CAS Number1374356-45-2
-
Formula Weight450.34
-
Molecular FormulaC21H22Cl2FN5O
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 12.5 mg/mL (27.76 mM)
-
SMILESC[C@@H](c1c(ccc(c1Cl)F)Cl)Oc1c(ncc(c1)c1cn(nc1)C1CCNCC1)N
-
Chemical Name3-[(1S)-1-(2,6-Dichloro-3-fluorophenyl)ethoxy]-5-[1-(4-piperidinyl)-1H-pyrazol-4-yl]-2-pyridinamine
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
-
TTA-Q6
TTA-Q6, a selective T-type Ca2+ channel antagonist, exhibits potential antitumor and immunomodulatory activities for treating neurological disorders by inhibiting the uptake of extracellular calcium ions by tumor cells, thereby inducing intracellular calcium deficiency and endoplasmic reticulum (ER) stress.
-
Pinaverium bromide
Pinaverium bromide is an calcium channel blocker with Antispasmodic and effectively relieves pain diarrhea and intestinal discomfort.
-
DS16570511
DS16570511 is a cellular osmotic inhibitor of mitochondrial calcium monoab, which blocks MCU or MICU1-dependent Ca2+ influx.DS16570511 dose - dependent inhibition of serum-induced mitochondrial Ca2+ influx in HEK293A cells with IC50 of 7 M.DS16570511 inhibits the uptake of isolated Ca2+. mitochondria from human cells, rat heart and pig heart.
Cart
sales@molnova.com